Reduced Acne Scars & Fine Lines : Our treatments are effective in reducing acne scars, fine lines, and wrinkles, providing smoother, younger-looking skin
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist December 18, 2024 6:45 am EST RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist
Additional proglucagon-derived peptides, including glicentin and oxyntomodulin, contribute to gastrointestinal regulation and appetite control
Zhu, Y., Liu, J., Park, J., Rai, P
Franchini, M